Aehr Test Systems

NASDAQ:AEHR

Semiconductors

Technology
$49.48 +4.72%

+$5.32 today

Market cap
$1.62B
Beta
3.18
P/E (TTM)
-317.1
EPS (TTM)
-$0.37
52W Low $10.89High $126.62

Volume 1.83M

Average 2.97M

AEHR Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Aehr Test SystemsNASDAQ: AEHR

Accounts Receivables · Q4 FY2026 · quarter ended May 2026

Accounts receivables growth accelerates

Q4 FY2026 accounts receivables of $5.69M (cash outflow) rose 174.4% year over year, ahead of the +8.9% change in trailing-twelve-month accounts receivables. Sequentially, it rose 278.6% from the prior quarter. Over 3 fiscal years it compounded at -4.4% a year.

Context

  • Accounts receivables amounted to 6.6% of revenue in FY2026, up 1.5 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +174.4% holds above the trailing-twelve-month pace of +8.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMay 2026
-$5.69M+278.6% QoQ
Last fiscal yearMay 2026
-$3.31M+8.9% YoY
LTMMay 2026
-$3.31M+8.9% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+174.4%——
1 year+8.9%——
3-year CAGR-4.4%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2026
(3.31M) USD
Year-over-year change
-8.9%

Accounts Receivables vs competitors

How AEHR compares with its peers on the latest reported figures

  • AEHR's LTM May 2026 accounts receivables of $3.31M is the smallest of the 5 companies compared; the peer median is $20.03M.
  • Its year-over-year change of +8.9% is the 2nd highest of 5, against a peer median of -349.3%.
  • Accounts receivables amounts to 6.5% of revenue for AEHR, versus a peer median of 7.0%.
AEHR Competitors Peer median
Accounts Receivables for AEHR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TERTeradyne, Inc.LTM Jun 2026$657.27M -1387.6%—14.7%
COHUCohu, Inc.LTM Jun 2026$35.85M -280.2%—6.9%
FORMFormFactor, Inc.LTM Sep 2026$7.92M +147.4%—0.8%
TRTTrio-Tech InternationalLTM Mar 2026$4.2M -418.3%-59.9%7.2%
AEHRAehr Test SystemsLTM May 2026$3.31M +8.9%-4.4%6.5%
Peer median (excluding AEHR) $20.03M-349.3%-59.9%7.0%

Competitors are the stored peer set for AEHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Net Income9.45M14.56M33.16M(3.91M)(7.13M)
Depreciation & Amortization307K450K1.36M3.39M3.53M
Deferred Income Tax00(20.77M)(421K)(4.72M)
Stock-Based Compensation3.01M02.52M5.16M6.76M
Change in Working Capital(9.56M)(7.28M)(14.38M)(12.2M)(1.79M)
Accounts Receivables(7.83M)(3.79M)6.79M(3.04M)(3.31M)
Inventory(6.67M)(9.47M)(13.73M)(2.44M)11K
Accounts Payables1.36M5.04M(3.89M)(714K)991K
Other Working Capital3.6M933K(3.55M)(6.01M)512K
Other Non-Cash Items(1.7M)2.28M(130K)584K33K
Operating Cash Flow1.51M10.01M1.76M(7.4M)(3.31M)
Capital Expenditures(416K)(1.36M)(749K)(4.99M)(2.07M)
Acquisitions (Net)000(11.08M)(1.8M)
Purchases of Investments0(33.29M)000
Sales of Investments016M18M00
Other Investing Activities00000
Investing Cash Flow(416K)(18.66M)17.25M(16.07M)(3.87M)
Debt Repayment(1.4M)0000
Common Stock Issued27.59M9.38M1.74M1.41M99.6M
Common Stock Repurchased(429K)(2.06M)(1.6M)(784K)(2.36M)
Dividends Paid00000
Other Financing Activities0000(20K)
Financing Cash Flow25.76M7.32M139K625K97.21M
Effect of Forex Changes49K(107K)(41K)(1.09M)(6K)
Net Change in Cash26.9M(1.43M)19.11M(23.93M)90.03M
Free Cash Flow1.09M8.65M1.01M(12.39M)(5.38M)

Aehr Test Systems

NASDAQ:AEHR

Intrinsic Alpha fair value

Locked

Current Price

$49.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.